Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral Blood Mononuclear Cell”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Testing effectiveness (Phase 2)Study completedNCT00250198
What this trial is testing

The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT03500614
What this trial is testing

The Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates

Who this might be right for
Blood PressureLung FunctionInflammation+1 more
Peking University 57
Not applicableLooking for participantsNCT05161702
What this trial is testing

Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).

Who this might be right for
Resolution of InflammationReduction of Cell Proliferation
SCF Pharma 200
Not applicableStudy completedNCT01895387
What this trial is testing

Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes

Who this might be right for
Impaired Fasting GlucoseNewly Diagnosed Type 2 Diabetes
Yonsei University 100
Not applicableNot Yet RecruitingNCT07340112
What this trial is testing

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

Who this might be right for
Peripheral Arterial Disease (PAD)Claudication, IntermittentChronic Limb-Threatening Ischemia
University Hospital, Strasbourg, France 50
Not applicableLooking for participantsNCT05775211
What this trial is testing

Effects of Intrauterine Administration of Autologous PBMC Modulated With IFNt on Endometrial Cell Populations

Who this might be right for
Infertility
Nadezhda Women's Health Hospital 300
Post-approval studies (Phase 4)Looking for participantsNCT06527534
What this trial is testing

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Universita di Verona 30
Testing effectiveness (Phase 2)Looking for participantsNCT05365672
What this trial is testing

Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplantation
TolerogenixX GmbH 126
Not applicableStudy completedNCT00977262
What this trial is testing

Postprandial Inflammation and Fatty Acids

Who this might be right for
Cardiovascular DiseaseDiabetes Type 2Obesity
Wageningen University 42
Not applicableLooking for participantsNCT04088370
What this trial is testing

Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT00234741
What this trial is testing

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Synta Pharmaceuticals Corp. 12
Testing effectiveness (Phase 2)UnknownNCT00003780
What this trial is testing

Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Meyer Pharmaceuticals 150
Not applicableUnknownNCT03343470
What this trial is testing

The Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS)

Who this might be right for
Cushing Syndrome
University of Roma La Sapienza 15
Not applicableStudy completedNCT00001109
What this trial is testing

A Blood Test to Look at Cells of the Immune System in Healthy Children

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 630
Testing effectiveness (Phase 2)Looking for participantsNCT06479239
What this trial is testing

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic Cancer
University of Virginia 23
Not applicableStudy completedNCT02272530
What this trial is testing

Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells

Who this might be right for
Red Blood CellPeripheral Blood Mononuclear CellEndothelial NO-synthase
Heinrich-Heine University, Duesseldorf 200
Not applicableLooking for participantsNCT05421364
What this trial is testing

Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells Populations

Who this might be right for
Female Infertility
Nadezhda Women's Health Hospital 300
Not applicableLooking for participantsNCT06503328
What this trial is testing

Role of Specific microRNAs in Cluster Headache

Who this might be right for
Cluster Headache
IRCCS National Neurological Institute "C. Mondino" Foundation 100
Early research (Phase 1)Looking for participantsNCT06792682
What this trial is testing

The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
Institute of Hematology & Blood Diseases Hospital, China 15
Early research (Phase 1)Study completedNCT02560220
What this trial is testing

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Failure, Chronic
Heidelberg University 14
Load More Results